MELISSA BROWN: Open Payments
NPI 1013486711 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 94 payments from 16 companies in 2025. Trend: 2023 $1,970 · 2024 $2,017 · 2025 $1,796
Food & beverage: $1,617Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $375 |
| UCB, Inc. | 12 | $297 |
| Mallinckrodt Hospital Products Inc. | 7 | $201 |
| PFIZER INC. | 12 | $158 |
| Janssen Biotech, Inc. | 6 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| Incyte Corporation | 8 | $141 |
| GENZYME CORPORATION | 4 | $98 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: Bimzelx, DUPIXENT, ACTHAR, RINVOQ, SKYRIZI, CIBINQO, TREMFYA, OPZELURA.
Industry payments across FL — which companies pay providers there.
